DermTech Inc

43.46+2.46+6.00%Vol 1.17M1Y Perf 251.01%
Apr 16th, 2021 16:00 DELAYED
BID42.01 ASK43.99
Open43.50 Previous Close41.00
Pre-Market- After-Market-
 - -  - -%
Target Price
43.67 
Analyst Rating
Strong Buy 1.00
Potential %
0.48 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★★+     55.00
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap1.25B 
Earnings Rating
Price Range Ratio 52W %
45.18 
Earnings Date
4th Mar 2021

Today's Price Range

41.2543.77

52W Range

9.6484.49

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Sell
Performance
1 Week
-10.58%
1 Month
-23.32%
3 Months
11.44%
6 Months
288.38%
1 Year
251.01%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
DMTK43.462.46006.00
AAPL134.16-0.3400-0.25
GOOG2 297.761.10000.05
MSFT260.741.24000.48
XOM56.66-0.3200-0.56
WFC43.841.60003.79
JNJ162.241.85001.15
FB306.18-1.6400-0.53
GE13.39-0.1600-1.18
JPM153.301.13000.74
Financial StrengthValueIndustryS&P 500US Markets
12.00
12.30
0.00
0.01
-73.90
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
-1.60
-578.00
-571.70
-
-
RevenueValueIndustryS&P 500US Markets
4.33M
0.15
-
-
Earnings HistoryEstimateReportedSurprise %
Q04 2020-0.54-0.4811.11
Q03 2020-0.58-0.5013.79
Q04 2019--0.08-
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-0.54
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume1.17M
Shares Outstanding28.76M
Trades Count13.59K
Dollar Volume80.98M
Avg. Volume1.50M
Avg. Weekly Volume1.24M
Avg. Monthly Volume1.32M
Avg. Quarterly Volume1.51M

DermTech Inc (NASDAQ: DMTK) stock closed at 43.46 per share at the end of the most recent trading day (a 6% change compared to the prior day closing price) with a volume of 1.17M shares and market capitalization of 1.25B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 64 people. DermTech Inc CEO is John D Dobak.

The one-year performance of DermTech Inc stock is 251.01%, while year-to-date (YTD) performance is 33.97%. DMTK stock has a five-year performance of %. Its 52-week range is between 9.64 and 84.49, which gives DMTK stock a 52-week price range ratio of 45.18%

DermTech Inc currently has a PE ratio of -24.10, a price-to-book (PB) ratio of 22.75, a price-to-sale (PS) ratio of 303.50, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -80.12%, a ROC of -86.93% and a ROE of -92.79%. The company’s profit margin is -%, its EBITDA margin is -571.70%, and its revenue ttm is $4.33 Million , which makes it $0.15 revenue per share.

Of the last four earnings reports from DermTech Inc, there were 2 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $-0.54 for the next earnings report. DermTech Inc’s next earnings report date is -.

The consensus rating of Wall Street analysts for DermTech Inc is Strong Buy (1), with a target price of $43.67, which is +0.48% compared to the current price. The earnings rating for DermTech Inc stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

DermTech Inc has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

DermTech Inc has a Sell technical analysis rating based on Technical Indicators (ADX : 30.90, ATR14 : 7.03, CCI20 : -111.02, Chaikin Money Flow : -0.02, MACD : -3.33, Money Flow Index : 46.53, ROC : -7.55, RSI : 40.66, STOCH (14,3) : 20.16, STOCH RSI : 0.54, UO : 41.45, Williams %R : -79.84), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of DermTech Inc in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (100.00 %)
1 (100.00 %)
1 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

DermTech Inc

DermTech Inc is an emerging growth molecular diagnostic company. The company is engaged in marketing and developing novel non-invasive genomic tests to aid in the diagnosis of various skin conditions, including skin cancer, inflammatory diseases, and aging-related conditions. While the company generates revenue through laboratory services.

CEO: John D Dobak

Telephone: +1 858 450-4222

Address: 11099 N. Torrey Pines Road, La Jolla 92037, CA, US

Number of employees: 64

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

54%46%

Bearish Bullish

58%42%

News

Stocktwits